Sex Differences in Ventricular Arrhythmias and Adverse Outcomes Following Acute Myocardial Infarction
- PMID: 39130035
- PMCID: PMC11312788
- DOI: 10.1016/j.jacadv.2024.101042
Sex Differences in Ventricular Arrhythmias and Adverse Outcomes Following Acute Myocardial Infarction
Abstract
Background: Ventricular arrhythmias (VAs) are a common cause of death in patients with acute myocardial infarction (AMI). Studies have shown sex differences in the incidence, presentation, and outcomes of AMI. However, less is known about sex differences in patients with AMI who develop VAs.
Objectives: The authors assessed sex differences in incidence and in-hospital outcomes of patients with AMI and VAs.
Methods: Using the National Inpatient Sample 2016 to 2020, we conducted a retrospective analysis of patients admitted for AMI with a secondary diagnosis of VAs. Multivariable logistic regression was performed to estimate the sex-specific differences in the rates and in-hospital outcomes of VAs post-AMI.
Results: We identified 1,543,140 patients admitted with AMI. Of these, (11.3%) 174,565 patients had VAs after AMI. The odds of VAs after AMI were higher among men (12.6% vs 8.8% adjusted odds ratio [AOR]: 1.72; CI: 1.67-1.78; P < 0.001). Women had significantly higher odds of in-hospital mortality (AOR: 1.32; CI: 1.21-1.42; P < 0.001), cardiogenic shock (AOR: 1.08; CI: 1.01-1.15; P < 0.022), and cardiac arrest (AOR: 1.11; CI: 1.03-1.18; P < 0.002). Women were less likely to receive an implantable cardioverter-defibrillator (ICD) (AOR: 0.57; CI: 0.47-0.68; P < 0.001) or undergo catheter ablation (AOR: 0.51; CI: 0.27-0.98; P < 0.001) during the index admission.
Conclusions: We found important sex differences in the incidence and outcomes of VAs among patients with AMI. Women had lower odds of VAs but worse hospital outcomes overall. In addition, women were less likely to receive ICD. Further studies to address these sex disparities are needed.
Keywords: acute myocardial infarction; sex or gender disparities; ventricular arrhythmias.
© 2024 The Authors.
Conflict of interest statement
Dr Kwaku has received consulting services to AltaThera, Anthos Therapeutics, Biosense Webster, and Janssen Scientific Affairs; travel support from Medtronic; and contracted research support from Boston Scientific. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures




References
-
- Bhar-Amato J. Ventricular arrhythmia after acute myocardial infarction: ‘the Perfect Storm’. 2017. https://www.aerjournal.com/articles/ventricular-arrhythmia-after-acute-m... - PMC - PubMed
-
- Masuda M., Nakatani D., Hikoso S., et al. Clinical impact of ventricular tachycardia and/or fibrillation during the acute phase of acute myocardial infarction on in-hospital and 5-year mortality rates in the percutaneous coronary intervention era. Circ J. 2016;80(7):1539–1547. doi: 10.1253/circj.CJ-16-0183. - DOI - PubMed
-
- Thomas D.E., Jex N., Thornley A.R. Ventricular arrhythmias in acute coronary syndromes—mechanisms and management. Contin Cardiol Educ. 2017;3(1):22–29. doi: 10.1002/cce2.51. - DOI
-
- Hersi A.S., Alhabib K.F., AlFaleh H.F., et al. Incidence of ventricular arrhythmia and associated patient outcomes in hospitalized acute coronary syndrome patients in Saudi Arabia: findings from the Registry of the Saudi Project for Assessment of Acute Coronary Syndrome (SPACE) Ann Saudi Med. 2012;32(4):372–377. doi: 10.5144/0256-4947.2012.372. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources